Revascularization or Optimal Medical Therapy for Stable Ischemic Heart Disease: A Bayesian Meta-Analysis of

Ashish Kumar1, Rajkumar Doshi2, Safi U Khan3

  • 1Department of Internal Medicine, Cleveland Clinic Akron General, Akron, OH, USA.

Insights

Revascularization in stable ischemic heart disease (SIHD) shows minimal impact on mortality but reduces myocardial infarction and unstable angina. However, it may increase stroke risk compared to optimal medical therapy alone.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Evidence-Based Medicine

Background:

  • The role of revascularization in stable ischemic heart disease (SIHD) remains debated, particularly with advancements in drug-eluting stents.
  • Optimal medical therapy (OMT) is the cornerstone of SIHD management, but the added benefit of revascularization is unclear.

Purpose of the Study:

  • To evaluate the absolute risk difference (ARD) between revascularization plus OMT versus OMT alone in patients with SIHD.
  • To utilize a Bayesian approach for a robust statistical analysis of outcomes.

Main Methods:

  • A systematic review and meta-analysis of randomized controlled trials (RCTs) identified through PubMed/MEDLINE and Cochrane.
  • Included trials compared initial revascularization (percutaneous or surgical) plus OMT against OMT alone, with >50% of patients receiving aspirin and statins in both arms.
  • Data were analyzed using a Bayesian approach to determine ARDs and probabilities.

Main Results:

  • Seven RCTs involving 12,494 patients were analyzed.
  • Revascularization showed minimal ARD for all-cause mortality (ARD: -0.002) and cardiac mortality (ARD: -0.0025).
  • Significant reductions were observed in myocardial infarction (MI) (ARD: -0.02) and unstable angina, with increased freedom from angina, but a higher risk of stroke.

Conclusions:

  • Revascularization in SIHD offers limited benefit for mortality reduction when compared to OMT alone.
  • Revascularization is associated with a lower incidence of MI and unstable angina, and improved angina relief.
  • The findings suggest a careful consideration of revascularization in SIHD due to potential increased stroke risk and minimal mortality benefit.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
53
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
44
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
56
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
40
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.6K
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
34